UBS O'Connor’s Cartesian Growth Corporation II Unit RENEU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-551,483
Closed -$5.52M – 1039
2022
Q3
$5.52M Sell
551,483
-55,208
-9% -$554K 0.06% 197
2022
Q2
$6.07M Buy
+606,691
New +$6.06M 0.06% 194

Other funds holding RENEU

UBS O'Connor's RENEU Position: Q4 2022 in Review

UBS O'Connor sold out of Cartesian Growth Corporation II Unit (RENEU) in Q4 2022, closing a stake of 551,483 shares — an estimated $5.52M sold.

UBS O'Connor first reported a position in RENEU in Q2 2022 and held it in 2 quarters. The position peaked at $6.07M in Q2 2022. 15 funds tracked by Wall St. Rank hold RENEU as of Q4 2022.

  • UBS O'Connor reported no remaining Cartesian Growth Corporation II Unit position as of Q4 2022 after selling out during the quarter.
  • UBS O'Connor sold 551,483 Cartesian Growth Corporation II Unit shares in Q4 2022, an estimated $5.52M.
  • UBS O'Connor first reported a position in Cartesian Growth Corporation II Unit in Q2 2022 and held it in 2 quarters.
  • UBS O'Connor's Cartesian Growth Corporation II Unit position peaked at $6.07M in Q2 2022.
  • 15 funds tracked by Wall St. Rank held Cartesian Growth Corporation II Unit as of Q4 2022.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.